Chung-Hsiun Wu

Title: Innovations of Chung-Hsiun Wu

Introduction

Chung-Hsiun Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment and diagnosis. With a total of 3 patents, his work has the potential to impact various medical applications.

Latest Patents

Wu's latest patents include groundbreaking innovations. One of his patents focuses on antibodies specific to alpha-enolase, which bind to the human ENO1 protein. This invention provides methods for treating ENO1 protein-related diseases, inhibiting cancer invasion, and diagnosing cancer. Another notable patent involves anti-human TIM-3 antibodies, which can bind specific peptides of the human TIM-3 protein. This antibody regulates immune cell activity and is useful in the diagnosis, prognosis, and treatment of cancers that express cell-surface TIM-3, such as lung, liver, and esophageal cancers.

Career Highlights

Throughout his career, Chung-Hsiun Wu has worked with esteemed organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Wu has collaborated with notable colleagues, including Ying-Yung Lok and Shih-Chong Tsai. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.

Conclusion

Chung-Hsiun Wu's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work in developing antibodies for cancer treatment and diagnosis showcases the potential for significant advancements in medical science.